Dongmin Shen

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 4 EPO patents. Top assignees: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Cspc Zhongqi Pharmaceutical Technology (Shijizhuang) Co. Ltd.. Active years: 2014-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongmin Shen. Retrieved from https://idiyas.com/inventor/dongmin-shen-nk4cyh9h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 7(Granted Patents)

Location History:

Hebei Province, CN (2014 - 2017)
Shijiazhuang, CN (2018 - 2020)
Hebei, CN (2014 - 2022)

Company Filing History:

6 out of 32

Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.

patents

1 out of 1

Cspc Zhongqi Pharmaceutical Technology (Shijizhuang) Co. Ltd.

patent

Years Active: 2014-2022

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11357728 - Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt (2022-06-14),

2. 10774079 - Quinazoline derivative (2020-09-15),

3. 10421754 - Quinazoline derivative (2019-09-24),

4. 10028913 - Liposomal pharmaceutical preparation and method for manufacturing the same (2018-07-24),

5. 9795585 - Methods of using L-butylphthalide for the prevention and treatment of cerebral ischemia disease (2017-10-24),

6. 8871253 - Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt (2014-10-28),

7. 8728518 - Butylphthalide self-emulsifying drug delivery system, its preparation and method and application (2014-05-20),

Title: Dongmin Shen: Pioneering Innovation in Pharmacology

Introduction: Dongmin Shen, a brilliant inventor hailing from Shijiazhuang, China, has made significant contributions to the field of pharmacology with a total of 7 patents to his name.

Latest Patents: Shen's recent patents include a groundbreaking liposome incorporating sulfobutyl ether cyclodextrin salt, and a novel quinazoline derivative with potential anti-cancer properties. These inventions showcase his commitment to advancing drug delivery and treatment options.

Career Highlights: Throughout his career, Dongmin Shen has been associated with esteemed companies such as CSPC Zhongqi Pharmaceutical Technology in Shijiazhuang. His innovative spirit and dedication to research have led to the development of cutting-edge pharmaceutical solutions.

Collaborations: Shen's collaborative efforts with coworkers like Chunlei Li and Lan Zhang have been instrumental in realizing his inventive ideas. Together, they have worked towards revolutionizing the pharmacological landscape.

Conclusion: Dongmin Shen stands as a testament to the power of innovation and perseverance in driving advancements in the pharmaceutical industry. His patents and collaborations underscore his position as a trailblazing inventor shaping the future of healthcare.

Profile summary based on public USPTO records.